thiophenes has been researched along with naloxone in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bansinath, M; Ramabadran, K; Shukla, VK; Turndorf, H | 1 |
| Bianchi, G; Colombo, M; La Regina, A; Petrillo, P; Tavani, A | 1 |
| Dissanayake, VU; Hill, RG; Hughes, J; Hunter, JC | 1 |
| Dollery, CT; Struthers, AD | 1 |
| Arato, M; Banki, CM; Kovacs, Z; Papp, Z; Vojnik, M | 1 |
| Besley, W; Gray, G; Nolan, AM; Reid, J | 1 |
| Headley, PM; Herrero, JF | 1 |
| Onoda, Y; Yamada, K | 1 |
| Grouhel, A; Wettstein, JG | 1 |
| Angel, F; Chevalier, E; Dahl, SG; Friese, N; Junien, JL; Pascaud, X; Riviere, PJ | 1 |
| Borsini, F; Cesana, R | 1 |
| Andre, N; Bellot, I; Bresson, Y; Deschamps, C; Pastoureau, P; Tordjman, C; Wierzbicki, M | 1 |
| Eisinger, DA; Schulz, R; Wehmeyer, A | 1 |
| Grandoso, L; Pineda, J; Torrecilla, M; Ugedo, L | 1 |
| Courteix, C; Eschalier, A; Fialip, J; Libert, F; Loiodice, S; Privat, AM; Wattiez, AS | 1 |
| Duprez, T; Hantson, P; Vinetti, M | 1 |
| Charkhpour, M; Ghanbarzadeh, S; Ghavimi, H; Jafari, RM; Parvizpur, A | 1 |
| da Silva Junior, FS; de Melo Leite, AC; de Melo Nunes, R; de Queiroz Cunha, F; Girão, VC; Marinho, AL; Martins, MR; Pinto, AC; Rocha, FA | 1 |
| Bruno, V; Farcy, N; Karnik, V; Zamorano, C | 1 |
| Fu, F; Li, B; Li, T; Wang, D; Wang, L; Wang, T; Zhang, L | 1 |
| Bartoszek, A; Binienda, A; Dziedziczak, K; Fabisiak, A; Fichna, J; Kordek, R; Krajewska, JB; Makaro, A; Mosińska, P; Niewinna, K; Salaga, M; Świerczyński, M; Talar, M; Tarasiuk, A | 1 |
| Chang, HF; Chang, YC; Chao, YS; Chen, CT; Ke, YY; Law, PY; Lin, SY; Loh, HH; Ou, LC; Shih, C; Tao, PL; Tien, YW; Ueng, SH; Xi, JH; Yeh, SH | 1 |
2 review(s) available for thiophenes and naloxone
| Article | Year |
|---|---|
Central nervous system mechanisms in blood pressure control.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Catecholamines; Clonidine; Disease Models, Animal; Ganglia, Sympathetic; Half-Life; Hypothalamus; Models, Neurological; Naloxone; Neurons; Nitroprusside; Norepinephrine; Phenylethanolamine N-Methyltransferase; Pressoreceptors; Propranolol; Rats; Rats, Inbred SHR; Receptors, Opioid; Reflex; Splanchnic Nerves; Thiophenes; Yohimbine | 1985 |
Current Status of Pain Management in Parkinson's Disease.
Topics: Acetylcholine Release Inhibitors; Alanine; Analgesics; Antiparkinson Agents; Apomorphine; Benzylamines; Botulinum Toxins, Type A; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Duloxetine Hydrochloride; Humans; Levodopa; Naloxone; Oxycodone; Pain; Pain Management; Pain Measurement; Pain Threshold; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2020 |
1 trial(s) available for thiophenes and naloxone
| Article | Year |
|---|---|
TRH-induced hormonal responses: the effect of pizotifene and naloxone.
Topics: Adjustment Disorders; Adult; Alcoholism; Female; Growth Hormone; Humans; Middle Aged; Naloxone; Pizotyline; Prolactin; Thiophenes; Thyrotropin; Thyrotropin-Releasing Hormone | 1985 |
19 other study(ies) available for thiophenes and naloxone
| Article | Year |
|---|---|
Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Baclofen; Benzeneacetamides; Benzomorphans; Cerebral Ventricles; Convulsants; Dizocilpine Maleate; Injections, Intraventricular; Ketamine; Mice; Mice, Inbred Strains; Muscimol; Naloxone; Narcotic Antagonists; Narcotics; Pyrroles; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Seizures; Stereoisomerism; Thiophenes | 1991 |
In vitro binding profile and in vivo pharmacological properties of the K-opioid compound PD 117302.
Topics: Analgesia; Animals; Binding Sites; Brain; Culture Techniques; Diprenorphine; Diuresis; Dose-Response Relationship, Drug; Gastrointestinal Transit; Injections, Intravenous; Male; Naloxone; Pain Measurement; Pyrroles; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Thiophenes | 1991 |
Characterization of kappa-opioid receptors in the guinea-pig ileum.
Topics: Animals; Benzeneacetamides; Benzomorphans; Binding, Competitive; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Guinea Pigs; Ileum; In Vitro Techniques; Kinetics; Muscle Contraction; Muscle, Smooth; Naloxone; Pyrroles; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Thiophenes | 1990 |
The effects of butorphanol on locomotor activity in ponies: a preliminary study.
Topics: Animals; Butorphanol; Drug Combinations; Female; Horses; Male; Motor Activity; Naloxone; Pyrroles; Receptors, Opioid, kappa; Receptors, Opioid, mu; Thiophenes | 1994 |
Functional evidence for multiple receptor activation by kappa-ligands in the inhibition of spinal nociceptive reflexes in the rat.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Anticonvulsants; Benzeneacetamides; Benzofurans; Blood Pressure; Decerebrate State; Male; Naloxone; Nociceptors; Piperazines; Pyrroles; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Reflex; Spinal Cord; Thiophenes | 1993 |
Comparison of the effects of T-1815, yohimbine and naloxone on mouse colonic propulsion.
Topics: Administration, Oral; Animals; Clonidine; Colon; Dose-Response Relationship, Drug; Gastrointestinal Motility; Loperamide; Male; Mice; Naloxone; Propylamines; Thiophenes; Yohimbine | 1993 |
Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Formaldehyde; Male; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Opioid, mu; Thiophenes | 1996 |
Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Acetic Acid; Analgesics; Animals; Benzofurans; Benzomorphans; Cyclazocine; Fentanyl; Gastric Emptying; Intestinal Pseudo-Obstruction; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Peritoneum; Pyrroles; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Thiophenes | 1997 |
Mechanism of action of flibanserin in the learned helplessness paradigm in rats.
Topics: Animals; Benzimidazoles; Escape Reaction; Helplessness, Learned; Male; Naloxone; Piperazines; Propanolamines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Thiophenes | 2001 |
General pharmacology of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
Topics: Acetic Acid; Air; Amides; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Gastric Mucosa; Hot Temperature; Hyperalgesia; Lipoxygenase Inhibitors; Male; Mice; Naloxone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Reaction Time; Stomach Diseases; Thiophenes | 2003 |
Opioid control of MAP kinase cascade.
Topics: Cell Line; Dipeptides; Epidermal Growth Factor; ErbB Receptors; Etorphine; Humans; Ligands; MAP Kinase Signaling System; Morphine; Naloxone; Narcotics; Oligopeptides; Phenylalanine; Phosphorylation; Receptors, sigma; Thiophenes; Transfection | 2004 |
alpha(2)-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amphetamines; Animals; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Citalopram; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Idazoxan; In Vitro Techniques; Locus Coeruleus; Male; Methiothepin; Naloxone; Narcotic Antagonists; Neurons; Norepinephrine; Oxazines; Piperazines; Piperidines; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiophenes | 2005 |
Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?
Topics: Analgesics; Animals; Antidepressive Agents; Clomipramine; Cyclopropanes; Diabetes Mellitus, Experimental; Disease Models, Animal; Duloxetine Hydrochloride; Hyperalgesia; Male; Milnacipran; Naloxone; Neuralgia; Rats; Rats, Sprague-Dawley; Thiophenes | 2011 |
Severe postoperative hyperthermic syndrome after addition of tilidine/naloxone to duloxetine therapy.
Topics: Aged; Analgesics; Brain; Drug Interactions; Duloxetine Hydrochloride; Female; Fever; Humans; Magnetic Resonance Imaging; Naloxone; Narcotic Antagonists; Narcotics; Neuroimaging; Postoperative Complications; Thiophenes; Tilidine | 2013 |
Duloxetine attenuated morphine withdrawal syndrome in the rat.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Injections, Intraperitoneal; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes | 2014 |
Strontium ranelate analgesia in arthritis models is associated to decreased cytokine release and opioid-dependent mechanisms.
Topics: Analgesics, Non-Narcotic; Animals; Arthralgia; Chemokine CXCL1; Cytokines; Dose-Response Relationship, Drug; Injections, Intra-Articular; Interleukin-1beta; Joints; Naloxone; Narcotic Antagonists; Osteoarthritis; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid; Thiophenes; Tumor Necrosis Factor-alpha | 2015 |
Rotigotine-loaded microspheres exerts the antinociceptive effect via central dopaminergic system.
Topics: Analgesics; Animals; Carrageenan; Corpus Striatum; Disease Models, Animal; Domperidone; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Inflammation; Injections; Male; Microspheres; Naloxone; Narcotic Antagonists; Pain; Periaqueductal Gray; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Stress, Mechanical; Temperature; Tetrahydronaphthalenes; Thiophenes | 2021 |
Characterization of the Synergistic Effect between Ligands of Opioid and Free Fatty Acid Receptors in the Mouse Model of Colitis.
Topics: Aniline Compounds; Animals; Butyrates; Colitis; Disease Models, Animal; Drug Synergism; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Inflammation; Ligands; Male; Mice; Mice, Inbred BALB C; Naloxone; Narcotic Antagonists; Peroxidase; Receptors, G-Protein-Coupled; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Sulfonamides; Thiophenes; Xanthenes | 2021 |
Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone.
Topics: Analgesics, Opioid; Imidazoles; Naloxone; Naltrexone; Receptors, Opioid; Sulfonamides; Thiophenes | 2022 |